By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Maxim Pharmaceuticals, Inc. 

8899 University Center Lane, Suite 400

San Diego  California  92122-1013  U.S.A.
Phone: 858-453-4040 Fax: 858-453-5005



Schering Corporation 

Celera Corporation  Collaboration to identify and develop novel small-molecule compounds that induce apoptosis, potential new therapies for certain cancers.


Mayne Group Limited 

Company News
Immune Pharma Signs Agreement To Fund Maxim Pharmaceuticals, Inc. (MAXM), Its Pain And Neurology Subsidiary 9/16/2016 8:41:28 AM
EpiCept Corporation Resolves All Remaining Litigation Against Maxim Pharmaceuticals, Inc. (MAXM) 10/5/2006 11:55:36 AM
EpiCept Corporation Settles Maxim Pharmaceuticals, Inc. (MAXM) Securities Litigation 3/27/2006 10:49:14 AM
EpiCept Corporation To Update Unaudited Pro Forma Financial Statements Of Merger With Maxim Pharmaceuticals, Inc. (MAXM) 3/24/2006 11:12:21 AM
EpiCept Corporation Completes Merger With Maxim Pharmaceuticals, Inc. (MAXM) 1/5/2006 1:20:51 PM
EpiCept Corporation Completes Merger With Maxim Pharmaceuticals, Inc. (MAXM) 1/5/2006 11:15:20 AM
EpiCept Corporation And Maxim Pharmaceuticals, Inc. (MAXM) Announce Trading And Listing Mechanics Upon Closing Of The Merger 12/28/2005 11:26:04 AM
Stockholders Of Maxim Pharmaceuticals, Inc. (MAXM) Approve Merger Proposal 12/21/2005 11:48:36 AM
Maxim Pharmaceuticals, Inc. (MAXM) Reports Fiscal 2005 Financial Results 12/14/2005 12:28:04 PM
Maxim Pharmaceuticals, Inc. (MAXM) Announces Initiation Of New Apoptosis Screening Campaign And Publication Of Manuscript In Journal Of Medicinal Chemistry10/19/2005 5:13:16 PM